7 employees
Edinburgh Molecular Imaging is a developer of systemic radiotherapy with cross cancer potential targeting c-Met
2014
$6.5M
from 2 investors over 2 rounds
Edinburgh Molecular Imaging Ltd raised undisclosed on March 7, 2016
Investors: Pitch@Palace
Edinburgh Molecular Imaging Ltd raised $6.5M on February 9, 2014
Investors: Epidarex Capital